Zollinger-Ellison Syndrome: A Patient Guide
At a Glance
Zollinger-Ellison syndrome is caused by gastrin-producing tumors that drive excess stomach acid, leading to recurrent ulcers and watery diarrhea. High-dose proton pump inhibitors control the acid, while surgery or long-term monitoring depends on tumor features and whether MEN1 is involved.
Zollinger-Ellison Syndrome (ZES) is a rare condition characterized by the development of one or more tumors called gastrinomas [1]. These tumors, typically found in the pancreas or the upper part of the small intestine, release an excessive amount of a hormone called gastrin. In a healthy body, gastrin acts as a messenger that tells the stomach to produce acid for digestion; however, in ZES, the tumors constantly signal the digestive system to produce excess gastric acid regardless of whether you have eaten [2]. This persistent overproduction overwhelms the body’s natural defenses, leading to severe, recurrent peptic ulcers and chronic, watery diarrhea [3].
Living with ZES requires managing two distinct but related medical challenges: the immediate danger of the stomach acid and the long-term management of the tumor itself. The excessive acid is not just a source of discomfort; if left untreated, it can cause severe complications like internal bleeding or a perforation (hole) in the stomach or intestinal lining [4]. To prevent this, the cornerstone of care is the use of high-dose acid-blocking medications known as proton pump inhibitors (PPIs). Because the gastrinomas are constantly signaling for acid, these medications must be taken consistently and should never be stopped abruptly or changed without medical supervision, as doing so can trigger a dangerous return of severe symptoms [5].
The underlying tumors can occur in two different ways. For many, a gastrinoma is a single, “sporadic” event that happens by chance. For others, it is part of a hereditary condition called Multiple Endocrine Neoplasia type 1 (MEN1), which may involve tumors in other hormone-producing glands like the parathyroid or pituitary [5][6]. Identifying which type of ZES you have is vital. While sporadic disease is sometimes approached with curative surgery (though not always, depending on whether it has spread), MEN1-associated ZES often requires a complex, long-term monitoring strategy to manage multiple small tumors over many years [7][8]. Your treatment decisions will depend on tumor location, grade, stage, and your personal health.
While a ZES diagnosis can feel overwhelming, modern medicine provides highly effective tools to control both the acid and the tumor. With the right team of specialists—including experts in gastroenterology, surgery, endocrinology, and oncology—most patients are able to find a balance that heals their ulcers, stops their symptoms, and allows them to focus on their long-term health and well-being [2][9]. Living with ZES is a journey of careful management, but it is one that can be navigated successfully with consistent care and a well-coordinated treatment plan [4].
In this guide
7 chapters
Confirming a Diagnosis of Zollinger-Ellison Syndrome
Learn how Zollinger-Ellison syndrome is confirmed using fasting gastrin, stomach pH, and secretin testing, plus safe PPI planning with your specialist.
Recognizing Symptoms and Warning Signs of ZES
Learn to recognize Zollinger-Ellison syndrome symptoms, including ulcers, diarrhea, reflux, and weight loss, plus urgent signs of bleeding or dehydration.
The Genetic Link: Understanding ZES and MEN1
Learn how Zollinger-Ellison syndrome relates to MEN1, including genetic risk, calcium and PTH screening, tumor patterns, and genetic counseling and testing.
Mapping the Tumor: Imaging and Staging for ZES
Learn how imaging finds and stages gastrinomas in Zollinger-Ellison syndrome, including DOTATATE PET/CT, EUS, CT, MRI, negative scans, and MEN1 monitoring.
Taming the Acid: Medical Management of ZES
Learn how Zollinger-Ellison syndrome is treated with high-dose PPIs, including dose adjustment, missed doses, fasting, long-term monitoring, and PPI safety.
Managing the Gastrinoma: Surgical and Medical Options
Learn how Zollinger-Ellison syndrome and gastrinoma are treated, including surgery, MEN1 decisions, PPIs, somatostatin analogues, PRRT, and tumor control.
Building Your Care Team and Long-Term Monitoring
Learn how Zollinger-Ellison syndrome care teams monitor acid control, PPI safety, gastrin levels, tumor imaging, MEN1 surveillance, and scan anxiety over time.
Common questions in this guide
What is Zollinger-Ellison syndrome, and what causes it?
What symptoms can Zollinger-Ellison syndrome cause?
Why are proton pump inhibitors important for ZES?
Is Zollinger-Ellison syndrome connected to MEN1?
Can surgery cure Zollinger-Ellison syndrome?
What should I do if I cannot take my acid-blocking medicine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How much experience does our medical center have in managing neuroendocrine tumors and gastrinomas specifically?
- 2.Is my ZES likely sporadic, or do I need to be screened for the MEN1 genetic syndrome?
- 3.What is the long-term plan for monitoring both my stomach acid levels and the behavior of the tumor?
- 4.If I am unable to take my acid-blocking medication for any reason, what is my emergency backup plan?
- 5.Can you explain the specific goals of my treatment—is it aimed at symptom management, tumor control, or a potential cure?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O, Schizas D, Vailas M, et al.
Journal of neuroendocrinology 2023; (35(4)):e13267 doi:10.1111/jne.13267.
PMID: 37042078 - 2
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE, Elvevi A, Citterio D, et al.
World journal of gastroenterology 2021; (27(35)):5890-5907 doi:10.3748/wjg.v27.i35.5890.
PMID: 34629807 - 3
Hypergastrinemia.
Dacha S, Razvi M, Massaad J, et al.
Gastroenterology report 2015; (3(3)):201-8 doi:10.1093/gastro/gov004.
PMID: 25698559 - 4
Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient.
Perrier M, Delemer B, Deguelte S, et al.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2021; (21(1)):236-239 doi:10.1016/j.pan.2020.12.002.
PMID: 33309626 - 5
Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.
Singh Ospina N, Donegan D, Rodriguez-Gutierrez R, et al.
The American journal of medicine 2017; (130(5)):603-605 doi:10.1016/j.amjmed.2016.11.035.
PMID: 28011308 - 6
[Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y, Chen LH, Liu M, et al.
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2021; (24(10)):875-882 doi:10.3760/cma.j.cn.441530-20210719-00291.
PMID: 34674462 - 7
How to treat gastrinomas in patients with multiple endocrine neoplasia type1: surgery or long-term proton pump inhibitors?
Imamura M, Komoto I, Taki Y
Surgery today 2023; (53(12)):1325-1334 doi:10.1007/s00595-022-02627-z.
PMID: 36473964 - 8
Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.
Shao QQ, Zhao BB, Dong LB, et al.
World journal of gastroenterology 2019; (25(32)):4673-4681 doi:10.3748/wjg.v25.i32.4673.
PMID: 31528093 - 9
[Management of gastrinoma].
Hain E, Coriat R, Dousset B, Gaujoux S
Presse medicale (Paris, France : 1983) 2016; (45(11)):986-991 doi:10.1016/j.lpm.2016.04.012.
PMID: 27262229
This page explains Zollinger-Ellison syndrome, gastrinomas, and long-term treatment for informational purposes only; it does not constitute medical advice. Do not stop or change acid-blocking medicine without guidance from your healthcare team.
Get notified when new evidence is published on Zollinger-Ellison syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.